Thomas Lehrnbecher | Medicine | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Goethe Universität Frankfurt | Germany

Dr. Thomas Lehrnbecher is a distinguished pediatric oncologist and hematologist, serving as Head of the Division of Pediatric Hematology and Oncology at Johann Wolfgang Goethe University, Frankfurt. With decades of experience, his clinical and research expertise lies in infections in immunocompromised pediatric patients, supportive care, and innovative therapeutic strategies for childhood cancers. His career spans leading roles in Germany and international collaborations at the National Cancer Institute, USA, where he trained as a post-doctoral fellow. A prolific researcher, he has published extensively in high-impact journals, shaping global practices in infection management and antifungal prophylaxis in children with cancer. Dr. Lehrnbecher has also contributed significantly to medical societies, committees, and working groups, reflecting his leadership in advancing pediatric oncology. Recognized with prestigious awards, he continues to drive progress in medicine through innovative research, clinical care, and mentorship, making him an influential figure in pediatric hematology and oncology worldwide.

Author profile 

Orcid

Education

Dr. Lehrnbecher’s medical training reflects a strong foundation in pediatrics and subspecialization in oncology and infectious diseases. He earned his Board Exam in General Pediatrics in 1996, establishing his clinical foundation. His academic excellence and leadership were recognized in 2005, when he was awarded a Professorship at Johann Wolfgang Goethe University, Frankfurt, one of Germany’s leading medical institutions. That same year, he also earned a Diploma in Pediatric Infectious Diseases from the German Society for Pediatric Infectious Diseases, strengthening his expertise in managing complex infections. In 2007, he completed his Board Exam in Pediatric Hematology and Oncology, formally certifying his specialization in childhood cancers and blood disorders. Combined with his post-doctoral fellowship at the National Cancer Institute (NIH, USA), his education and training provided him with exceptional clinical and research competencies, which now serve as the foundation of his international reputation in pediatric oncology and infection medicine.

Experience

Dr. Lehrnbecher has cultivated an impressive career spanning over two decades in pediatric hematology and oncology. Since 2001, he has served as a Senior Consultant at Johann Wolfgang Goethe University, Frankfurt, providing expertise in pediatric cancer care and mentoring young clinicians. In 2018, he advanced to Head of the Division of Pediatric Hematology and Oncology, where he oversees patient care, clinical programs, and research initiatives. Earlier in his career, he worked as a Consultant at the Children’s Hospital, University of Würzburg (1999–2000), where he gained valuable clinical insights. A pivotal moment came during his post-doctoral fellowship at the National Cancer Institute, NIH, USA (1996–1999), under Dr. Stephen Chanock, where he developed a strong research focus on infections in immunocompromised children. His leadership in both clinical and research settings reflects his dedication to integrating science with practice, driving advancements in pediatric oncology, supportive care, and infection management worldwide.

Awards and Honors

Dr. Lehrnbecher’s contributions to pediatric oncology and infectious diseases have earned him numerous prestigious awards. In 2024, he received the Best Publication Award from the German Society of Mycology (DMykG), recognizing his impactful research. He previously won the Kind Philipp Award from the German Society of Pediatric Oncology and Hematology (GPOH) and the Poster Award from the International Society of Pediatric Oncology (SIOP). His groundbreaking work in mycology earned him the Outstanding Research in Mycology Award, while his contributions to histiocytic disorders were honored with the Nesbit Award from the Histiocyte Society. Earlier in his career, he was recognized with the Outstanding Research Award in Novel Therapeutic Strategies by the Children’s Cancer Foundation Mainz and the Educational Grant from the German Foundation of Cancer Aid. Collectively, these awards highlight his sustained excellence in clinical care, medical research, and innovation.

Research Focus

Dr. Lehrnbecher’s research is centered on improving the management of infections in immunocompromised pediatric patients, particularly those undergoing cancer treatment or hematopoietic stem cell transplantation. He has extensively studied antifungal prophylaxis, bacterial infections, and novel diagnostic markers for invasive fungal disease in children. His investigations aim to refine supportive care strategies, reduce infection-related mortality, and improve the quality of life for pediatric cancer patients. A particular focus of his research has been the efficacy of antifungal and antibiotic therapies, as well as the development of evidence-based guidelines for infection management. Beyond infectious diseases, his work also contributes to optimizing cancer treatment protocols, including long-term maintenance therapies for pediatric sarcomas. Through clinical trials, prospective studies, and international collaborations, Dr. Lehrnbecher has made significant advances in pediatric oncology. His contributions are widely recognized for bridging research and practice, helping set global standards for supportive care in children with cancer.

Publications

  • Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients.

  • Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.

  • Pediatric Patients with Stage IV Rhabdomyosarcoma Benefit from Long-Term Maintenance Therapy: CWS Trials Results.

  • Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Children: A Critical Analysis.

  • Cerebrospinal Fluid System Infection in Children with Cancer: A 14-Year Retrospective Analysis.

  • Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients: A Prospective European Study.

Conclusion

Dr. Thomas Lehrnbecher is an internationally recognized leader in pediatric oncology and infectious diseases. His pioneering research, clinical leadership, and commitment to advancing supportive care in childhood cancer treatment have transformed patient outcomes worldwide. His achievements and continued impact make him a highly deserving candidate for the Medicine Award, symbolizing excellence in medical research and clinical innovation.

Sarah Depallens | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Sarah Depallens | Medicine | Best Researcher Award

👤 Dr. Sarah Depallens, CAN team Lausanne CHUV, Switzerland

Dr. Sarah Depallens, an accomplished pediatrician born on February 15, 1977, in Lausanne, Switzerland, has made a profound impact in child healthcare. Serving as an Associate Physician at CHUV, she leads the CAN Team (since 2017), the General Pediatrics Outpatient Clinic (since 2023), and the Migratory Pediatrics Consultation (since 2024). Her career spans two decades, marked by expertise in pediatrics, child abuse prevention, and healthcare for vulnerable populations. Dr. Depallens earned her medical degree from the University of Lausanne in 2002 and became a FMH Specialist in Pediatrics in 2011. Her dedication to improving pediatric care is evident in her extensive professional experience, numerous publications, and advocacy for child welfare. Fluent in multiple languages and globally oriented, she is known for her compassionate approach and leadership in addressing healthcare challenges for children and adolescents.

Professional Profile

Orcid

🌟  Suitability for the Research for Best Researcher Award: Dr. Sarah Depallens

Dr. Sarah Depallens exemplifies the qualities of an outstanding researcher and academic leader, making her a highly suitable candidate for the Research for Best Researcher Award. Her extensive professional experience in pediatrics, public health, and migration health reflects a deep commitment to advancing the field and addressing complex societal challenges. As a Médecin Associé and leader of multiple pediatric initiatives at the CHUV (Centre Hospitalier Universitaire Vaudois), Dr. Depallens demonstrates exceptional leadership, innovation, and dedication to improving healthcare for vulnerable populations.

Research Contributions and Professional Impact : Dr. Depallens has significantly contributed to academic research, with an impressive array of publications in high-impact journals addressing critical topics such as child abuse detection, pediatric refugee healthcare, and the psychological impacts of migration on children. Her work combines clinical expertise with public health strategies, as seen in her studies on abusive head trauma, migrant health, and pediatric violence exposure.

🎓 Education 

Dr. Sarah Depallens’ academic journey reflects a commitment to excellence in medicine. She earned her medical degree in 2002 from the University of Lausanne, followed by a doctorate in 2010 with her thesis on healthcare for undocumented children. Dr. Depallens holds the FMH Pediatric Specialist title (2011), reinforcing her expertise in pediatrics. Further enriching her professional profile, she obtained certifications in Public Health (2012) from KMC, India, and medico-legal care for violence survivors (2013). Recognizing the importance of leadership, she completed a CAS in Management for Executives (2017) and a MicroMBA (2024) at CHUV. Her diverse educational experiences include international rotations in Mexico, Cuba, and Switzerland, offering a well-rounded perspective on healthcare challenges. This robust educational foundation underpins her innovative work in pediatric care, advocacy, and research.

💼  Professional Experience 

Dr. Sarah Depallens’ professional journey spans over 20 years, reflecting her expertise in pediatrics and leadership. She began as a Medical Assistant in General Pediatrics (2003-2004) and expanded her experience through roles in Pediatric Surgery, Emergency Medicine, and Neonatology at CHUV and HEL in Lausanne. From 2008 to 2016, she held pivotal roles in multidisciplinary pediatric units, specializing in adolescent health and child abuse prevention. Her international experience includes a year in General Pediatrics at KMC Hospital, India (2011-2012). Since 2017, Dr. Depallens has led the CAN Team at CHUV, addressing child abuse with innovative strategies. She also heads the General Pediatrics Outpatient Clinic and Migratory Pediatrics Consultation, emphasizing healthcare for marginalized children. Her holistic approach and leadership have established her as a pioneer in pediatric medicine.

🏅 Awards and Recognitions

Dr. Sarah Depallens has received several accolades for her contributions to pediatrics. Her pioneering work in child abuse prevention and healthcare for vulnerable populations has earned her recognition both nationally and internationally. She received CHUV’s Excellence in Leadership Award (2020) for her innovative strategies in multidisciplinary pediatric care. Her thesis on undocumented children’s health was awarded the Best Research Thesis by the University of Lausanne (2010). Additionally, her efforts in medico-legal pediatric care earned her the Swiss Pediatric Society Recognition Award (2018). Dr. Depallens has also been lauded for her global outreach, receiving a Certificate of Public Health distinction from KMC, India (2012). Through her publications and advocacy, she continues to inspire advancements in child healthcare, cementing her reputation as a leader in pediatrics.

🌍 Research Skills On Medicine 

Dr. Sarah Depallens’ research skills center on pediatrics, public health, and child abuse prevention. She excels in designing multidisciplinary studies, evidenced by her work on abusive head trauma and the health needs of migrant children. Proficient in quantitative and qualitative methodologies, she collaborates with experts in pediatrics, psychology, and law to develop comprehensive insights into child welfare. Dr. Depallens’ ability to analyze complex data has led to over 20 peer-reviewed publications, addressing topics like pediatric refugees, adolescent health, and medico-legal evaluations. Her research often translates into actionable policies, underscoring her skill in bridging science and practice. Adept in academic writing and presentation, she shares findings at international conferences, fostering global collaboration.

📖 Publication Top Notes

  • Maternal risk factors for infant foster care from birth: a retrospective observational study
    • Authors: Inés Blanco Lara, Antje Horsch, Roger Hilfiker, Sarah Depallens, Vania Sandoz
    • Year: 2025
  • Enfants et adolescent-e-s dans un environnement négligent. La détection précoce comme première réponse à leurs besoins
    • Authors: Cyril Knob, Vania Sandoz, Sarah Depallens
    • Year: 2024
  • Pédiatrie. Consultation en pédiatrie pour les enfants victimes de violence conjugale
    • Authors: Janique Sangsue, Vania Sandoz, Edelweiss Kabwiku, Sarah Depallens
    • Year: 2024
  • Prosecuting cases of abusive head trauma in Switzerland: a descriptive study of the impact of medical documentation and delay of reporting on judicial outcome
    • Authors: Sarah Held, Jean-Jacques Cheseaux, Jean-François Tolsa, Sarah Depallens
    • Year: 2024
  • SECURE: un outil pour évaluer les mineurs victimes de violences conjugales
    • Authors: Janique Sangsue, Sarah Depallens
    • Year: 2023
  • [Assessment of families in situations of forced migration: Transcultural approaches to identifying and supporting psychological suffering].
    • Authors: Javier Sanchis Zozaya, Sydney GAULTIER, Sarah Depallens
    • Year: 2023
  • Paediatric refugees from Ukraine: guidance for health care providers.
    • Authors: Jaeger FN, Christoph Berger, Michael Buettcher, Sarah Depallens, Heininger U, Heller Y, Kohns Vasconcelos M, Leforestier B, Pellaud N, Relly C et al.
    • Year: 2022
  • [Mobbing amongst students: from detection to care: How to work together?]
    • Authors: Redzepi V, Sangsue J, Lugon J, Sarah Depallens
    • Year: 2022
  • Early Diagnosis of Abusive Head Trauma to Avoid Repetitive Shaking Events
    • Authors: Sarah Depallens, Celine Favrod, Philippe Maeder, Diego San Millan, Jean-Jacques Cheseaux
    • Year: 2022
  • Jugendliche mit Migrationshintergrund – Herausforderung für die allgemeine Gesundheit, über welche Hilfsmittel verfügen Kinderärztinnen und Kinderärzte?
    • Authors: Sarah Depallens, Caroline Heiniger, Karine Tzaud
    • Year: 2021